Crestchem Ltd is Rated Sell

1 hour ago
share
Share Via
Crestchem Ltd is rated 'Sell' by MarketsMojo, with this rating last updated on 16 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 July 2026, providing investors with the latest insights into the company’s performance and outlook.
Crestchem Ltd is Rated Sell

Current Rating and Its Significance

MarketsMOJO’s 'Sell' rating for Crestchem Ltd indicates a cautious stance towards the stock, suggesting that investors may want to consider reducing their exposure or avoiding new purchases at this time. This rating is derived from a comprehensive evaluation of the company’s quality, valuation, financial trend, and technical indicators. It reflects an assessment that the stock currently does not offer an attractive risk-reward profile relative to its peers and market benchmarks.

Quality Assessment

As of 30 July 2026, Crestchem Ltd’s quality grade is classified as below average. This assessment takes into account factors such as return on equity (ROE), profit consistency, and operational efficiency. The company reports a robust ROE of 27.4%, which is a positive indicator of profitability relative to shareholder equity. However, despite this strong ROE, other quality metrics suggest challenges in sustaining growth and operational stability, which temper the overall quality grade.

Valuation Considerations

The valuation grade for Crestchem Ltd is currently deemed expensive. The stock trades at a price-to-book (P/B) ratio of 4.1, indicating a significant premium compared to its historical averages and peer group valuations. This elevated valuation suggests that the market has priced in optimistic expectations for future growth, which may not be fully supported by the company’s recent financial performance. Investors should be cautious as paying a premium valuation increases the risk of downside if growth expectations are not met.

Financial Trend Analysis

Financially, Crestchem Ltd shows a positive trend, with some encouraging signs in recent quarters. Despite a slight decline in profits by 0.7% over the past year, the company has demonstrated resilience in its core operations. The stock’s returns over various time frames present a mixed picture: while the one-year return stands at -17.29%, shorter-term returns have been more favourable, with a 6-month gain of 55.60% and a 3-month increase of 18.44%. This divergence suggests some recent recovery momentum, although the longer-term underperformance relative to the broader market remains a concern.

Technical Indicators

From a technical perspective, Crestchem Ltd is rated mildly bullish. The stock has experienced positive price movements recently, with a 4.2% gain on the day of 30 July 2026 and steady appreciation over the past month and week. These technical signals indicate some buying interest and potential short-term strength. However, technical optimism is tempered by the broader fundamental challenges and valuation concerns, which limit the stock’s appeal for risk-averse investors.

Comparative Market Performance

When compared to the broader market, Crestchem Ltd has underperformed notably over the past year. The BSE500 index has generated a modest return of 0.94% in the same period, while Crestchem’s stock has declined by approximately 16.70%. This underperformance highlights the stock’s relative weakness and reinforces the cautious stance reflected in the 'Sell' rating. Investors should weigh this against the company’s sector dynamics and individual prospects before making investment decisions.

Implications for Investors

The 'Sell' rating serves as a signal for investors to carefully evaluate their holdings in Crestchem Ltd. Given the expensive valuation and below-average quality metrics, the stock may face headwinds if market conditions deteriorate or if the company fails to improve its financial trajectory. While recent technical strength and positive financial trends offer some hope, these factors do not currently outweigh the risks identified in the valuation and quality assessments.

Summary of Key Metrics as of 30 July 2026

  • Mojo Score: 44.0 (Sell Grade)
  • ROE: 27.4%
  • Price to Book Value: 4.1 (Expensive)
  • 1-Year Stock Return: -17.29%
  • 6-Month Stock Return: +55.60%
  • Market Benchmark (BSE500) 1-Year Return: +0.94%
  • Technical Grade: Mildly Bullish

Our current Stock of the Month is out! This Large Cap from Automobiles - Passenger Cars emerged as the single best opportunity from our elite universe. Get the details now!

  • - Current monthly selection
  • - Single best opportunity
  • - Elite universe pick

Get the Full Details →

Understanding the Rating Framework

MarketsMOJO’s rating system integrates multiple dimensions to provide a holistic view of a stock’s investment potential. The quality grade assesses the company’s profitability, earnings stability, and operational efficiency. Valuation grade compares current market prices against intrinsic and historical values to identify over- or undervaluation. Financial trend analysis examines recent performance trajectories, including revenue and profit growth. Technical grading evaluates price momentum and chart patterns to gauge market sentiment.

For Crestchem Ltd, the combination of below-average quality and expensive valuation outweighs the positive financial trend and mild technical bullishness, resulting in the 'Sell' rating. This balanced approach helps investors understand not just the current recommendation but the underlying rationale, enabling more informed portfolio decisions.

Sector and Market Context

Crestchem Ltd operates within the specialty chemicals sector, a space often characterised by cyclical demand and sensitivity to raw material costs. Microcap status adds an additional layer of volatility and liquidity considerations. Investors should factor in these sector-specific risks alongside company fundamentals when evaluating Crestchem’s stock.

Conclusion

In summary, Crestchem Ltd’s 'Sell' rating as of 16 July 2026 reflects a cautious outlook based on a thorough analysis of quality, valuation, financial trends, and technical factors. As of 30 July 2026, the stock’s current metrics confirm the challenges inherent in its valuation and quality profile, despite some recent positive price momentum and financial resilience. Investors are advised to carefully consider these factors in the context of their investment objectives and risk tolerance.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News